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Abstract
Objective To study the prevalence, impact and dose–re-
sponse relationship of comorbid chronic conditions on
quality of life of type 2 diabetes patients.
Research design and methods Cross-sectional data of
1676 type 2 diabetes patients, aged 31–96 years, and
treated in primary care, were analyzed. Quality of life
(QoL) was measured using the mental component summary
(MCS) and the physical component summary (PCS) scores
of the Short Form-12. Diagnosis of type 2 diabetes was
obtained from medical records and comorbidities from
self-reports.
Results Only 361 (21.5 %) of the patients reported no
comorbidities. Diabetes patients with comorbidities
showed significantly lower mean difference in PCS [-8.5;
95 % confidence interval (CI) -9.8 to -7.3] and MCS
scores (-1.9; 95 % CI -3.0 to -0.9), compared to dia-
betes patients without. Additional adjustments did not
substantially change these associations. Both MCS and
PCS scores decrease significantly with the number of
comorbid conditions, yet most pronounced regarding
physical QoL. Comorbidities that reduced physical QoL
most significantly were retinopathy, heart diseases,
atherosclerosis in abdomen or legs, lung diseases, incon-
tinence, back, neck and shoulder disorder, osteoarthritis
and chronic rheumatoid arthritis, using the backwards
stepwise regression procedure.
Conclusion Comorbidities are highly prevalent among
type 2 diabetes patients and have a negative impact on the
patient’s QoL. A strong dose–response relationship between
comorbidities and physical QoL was found. Reduced
physical QoL is mainly determined by musculoskeletal and
cardiovascular disorders.
Keywords Type 2 diabetes  Comorbidities  Quality of
life  Primary care
Introduction
Quality of life is an important patient reported outcome in
the diabetes research field. Quality of life incorporates the
patient’s perspective of his/her physical, mental and social
well-being. The importance of achieving and maintaining a
good quality of life is increasingly been recognized, and
stated in diabetes guidelines, [1] and represents in general
an important goal for health care on its own.
Poor quality of life is associated with adverse outcomes
in people with type 2 diabetes, including poor response to
therapy, disease progression, and cardiovascular mortality
[2, 3]. Complications and comorbid conditions primarily
determine the quality of life of diabetes patients [4]. A
considerable proportion of diabetes patients develop dis-
ease related complications such as cardiovascular disease,
nephropathy, retinopathy and neuropathy. However, non-
diabetes related comorbid conditions are also common
among people with diabetes [5]. Comorbidities can have
profound effects on patient’s ability to manage their self-
care and pose significant barriers to lifestyle changes and
regimen adherence [6].
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So far, the role of comorbidities on diabetes patient’s
mental and physical quality of life is understudied. The
number of studies that have reported both about the
prevalence, impact and the dose–response relationship
between comorbidity and quality of life in type 2 diabetes
patients is limited. The interactions of diabetes and
comorbid conditions are becoming increasingly important
as the prevalence of individuals with diabetes and multiple
chronic conditions increases [7, 8].
Therefore, our aim was to study the prevalence, impact
and the dose–response relationship of comorbid chronic
conditions on mental and physical quality of life in type 2
diabetes patients. A better understanding of the influence of
comorbid conditions on quality of life in diabetes patients
might also underscore the importance of preventing and
treating comorbidity in individuals with diabetes. Ulti-
mately, this may lead to improvements in the comprehen-
sive management of diabetes patients and subsequently
increase their quality of life.
Research methods and design
Study design and population
Data were derived from an observational study evaluating
the effects of bundled payment on the healthcare delivery
process and quality of diabetes care, provided by Dutch
care groups. For the observational study, care groups were
selected based on size, catchment area, geographical
location and composition (e.g., rural vs urban), and their
organizational structure. Care groups are groups of asso-
ciated care providers, often exclusively general practi-
tioners, who are responsible for coordinating and ensuring
the delivery of services included in the disease manage-
ment program [9]. Care groups can decide to either deliver
the various diabetes care components themselves or sub-
contract other care providers. Detailed information about
this payment reform, the related evaluation and the meth-
ods is published elsewhere [10, 11]. For the present study,
we used data over a period from June 2009 to June 2010.
The current study population consists of type 2 diabetes
patients available from eight care groups in the
Netherlands.
Data collection
Data were collected from two data sources: patient medical
records and patient survey questionnaires completed by
patients enrolled in the disease management programmes
of the care groups. As part of the observational study, a
patient survey was administered to a random sample of
4377 diabetes patients clustered within a random sample of
78 general practices, which were subcontracted by eight
care groups. A reminder was sent three weeks later to all
who had not yet responded. A total of 1941 (response rate:
44 %) patient questionnaires were completed and returned.
To link patients’ survey questionnaire data to medical
record data, patient surveys were given pseudonymous
identification numbers before they were distributed. Of the
1941 completed questionnaires 1714, (88 %) could be
linked to patients medical records; 38 patients with type 1
diabetes cases were excluded. The final study sample
consisted of 1676 type 2 diabetes patients.
Quality of life
Quality of life was measured using Short Form-12 (SF-12).
The SF-12 is a generic, reliable and validated instrument,
containing 12 items derived from the Short Form-36
questionnaire [12]. Physical and mental quality of life was
measured using the physical component summary (PCS)
and mental component summary (MCS) scores of the SF-
12, respectively. The PCS items include an assessment of
the participant’s self-report on the level of limitations
experienced in performing moderate activities, climbing
stairs, accomplishing less because of physical health, the
experience of bodily pain, and a rating of general health.
The MCS items include questions on feeling calm and
peaceful, downhearted and blue, accomplishing less, and
doing activities less carefully than usual because of one’s
mental health. The SF-12 is recommended for use in large
surveys and has been used in diabetes populations before
[13, 14]. Both the PCS and MCS score range from 0
(worse) to 100 (best). Dutch age- and sex-standardized
population norms are available [15, 16]. In adults aged
60–69, the mean PCS score is 50.9 ± 8.3, and the mean
MCS score is 51.3 ± 8.8 points [16]. A higher score in the
respective summary scales represents a higher level of
functioning. It is suggested that a minimum difference in
three to five points is considered clinically important [17].
Comorbid chronic conditions
The presence of comorbidities was determined through the
patient questionnaire using a fixed list of 16 chronic con-
ditions. This list was derived from the permanent survey on
living condition (PSLC). The PSLC is yearly administered
to a random sample of the Dutch population to gain insight
into trends in health, medical consumption, and aspects of
life style. The fixed list of conditions is developed under
the auspices of Statistics Netherlands and has been applied
regularly in health surveys in the Netherlands in the last
decades [18]. Respondents were asked whether they had
suffered from one of the following 16 conditions in the last
12 months: (1) retinopathy; (2) cerebral diseases (i.e.,
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stroke, cerebral hemorrhage, cerebral infarct, or transient
ischemic attack); (3) myocardial infarction; (4) severe heart
disease (such as congestive heart failure or angina pec-
toris); (5) cancer/malignancies; (6) migraine or frequent
severe headache; (7) high blood pressure; (8) atheroscle-
rosis in abdomen or legs; (9) lung diseases (i.e., asthma,
chronic bronchitis, lung emphysema or chronic obstructive
pulmonary disease (COPD); (10) intestine disorder (severe
and persistent for more than 3 months); (11) incontinence;
(12) back disorder (severe/persistent); (13) osteoarthritis
(hip, knee); (14) chronic rheumatoid arthritis; (15) neck,
shoulder disorder (severe/persistent); and (16) elbow, wrist
and hand disorder (severe/persistent).
Other variables
Patient questionnaires and patient medical records were
used to define the other variables. The self-administered
patient questionnaire consisted of questions on education,
ethnicity, smoking and physical activity. These variables
were derived from standard questionnaires used in the
Dutch National Health Survey. Education was categorized
into: low (primary school, lower occupational education or
less), medium (secondary level education) and high edu-
cation (university, higher occupational or corresponding
education). Smoking status was defined as currently
smoking or not. Physical activity was assessed with two
questions covering time spent on leisure time activities
such as walking, bicycling, odd jobs, sports, and gardening
and sport activities during the week. A summary score of
both physical activity questions was calculated (range 0–7).
Patient record data included general patient characteristics
including sex, age, body mass index [calculated by divid-
ing weight (kg) by height squared (m2)], HbA1c level,
insulin use, diabetes duration (defined as number of years
since diagnosis) and systolic blood pressure (SBP). The
diagnosis of type 2 diabetes was obtained from medical
records. Type 2 diabetes patients were diagnosed according
to the World Health Organisation/International Diabetes
Federation (WHO/IDF) 2006 criteria. The diagnosis was
verified by the general practitioners.
Missing values
Missing values were computed, for both patient registration
data (i.e., HbA1c) and survey data (i.e., Quality of life)
using multivariate imputation by chained equations
(MICE) procedure in R [19]. Twenty imputation datasets
were created. Analyses were performed with the multiple
imputed datasets [20]. The necessary number of iterations
for each missing value was 40 based on the Gibbs sampler
[19]. Results of the analyses on the twenty imputed datasets
were pooled by the MIANALYZE procedure in SAS.
Statistical analysis
Descriptive data are presented for the total sample and type
2 diabetes patients with and without comorbidities. Dif-
ferences in study sample characteristics for patients with
and without comorbidities were examined using t tests for
continue variables and Chi-square tests for dichotomous
and categorical variables. Next, mean differences in mental
(MCS) and physical (PCS) scores of quality of life by
comorbid chronic condition in type 2 diabetes patients were
calculated. These analyses were calculated and adjusted for
age, sex, duration of diabetes, HbA1c, low-density
lipoprotein cholesterol, systolic blood pressure, body mass
index, insulin use, current smoking and physical activity.
Thereafter, unadjusted and adjusted Beta coefficients for
MCS and PCS scores of quality of life by number of
comorbid chronic conditions [0 (reference category), 1, 2, 3,
and 4 or more] among type 2 diabetes patients were cal-
culated. Additionally, we performed analysis of variance
(ANOVA) to test the differences in unadjusted and adjusted
mean PCS and MCS scores by number of comorbid chronic
condition. Finally, linear regression analyses were applied
to determine the associations between comorbidities and
PCS score in the group of diabetes patients with comor-
bidities only. The influence of comorbidities was analyzed
for each comorbid chronic condition independently and in
combination (backwards stepwise regression elimination
procedure). The backwards elimination procedure has an
advantage over forward selection and stepwise regression as
it is possible for a set of variables to have considerable
predictive capability even though any subset of them does
not. Forward selection and stepwise regression would fail to
identify them. Backwards elimination starts with all vari-
ables (i.e., comorbidities and demographics) in the model,
so their joint predictive capability can be detected. For all
statistics, we used two-sided hypotheses testing with an
alpha level of 0.05. All analyses were performed using SAS
(version 9.3, SAS Institute Inc, Cary, NC).
Results
In total 1676 type 2 diabetes patients were included, aged
31–96 years (mean age 67.3 ± 11.1), of which 846 were
male (50.5 %). Out of the total sample, 361 subjects
(21.5 %) had no comorbid chronic conditions. The study
sample characteristics and mean quality of life scores in
diabetes patients with and without comorbidities are pre-
sented in Table 1. Diabetes patients with comorbidities
were older, were more often females, had a higher body
mass index, were more often smokers, were less physical
active, had more often a Western ethnicity, and had higher
systolic blood pressure, compared with diabetes patients
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without comorbidities, whereas HbA1c levels, low-density
lipoprotein cholesterol levels and diabetes duration did not
differ.
Quality of life
Diabetes patients with comorbid chronic conditions
showed significantly lower PCS (-8.5; 95 % confidence
interval (CI) -9.8 to -7.3) and MCS scores (-1.9; 95 %
CI 3.0 to -0.9), compared with patients without comor-
bidities. After adjustment, these associations attenuated
slightly though remained statistically significant; PCS
(-6.9; 95 % CI -8.0 to -5.7) and MCS scores (-1.6;
95 % CI -2.6 to 0.5; data not shown).
QoL by comorbid chronic condition
High blood pressure, osteoarthritis and neck and shoulder
disorders were the most common comorbid conditions
among type 2 diabetes patients (Table 2). All comorbid
conditions are associated with decreased physical QoL,
with the exception of cancer/malignancies. Osteoarthritis,
chronic rheumatoid arthritis and neck and shoulder disor-
der have the most negative impact on PSC with each mean
difference scores of C-8.0 points. In contrast, 4 out of 16
chronic conditions showed no mean difference MCS
scores. Migraine/severe headache and intestine disorders
showed the most negative impact on MCS, with mean
differences scores of -6.34 and -5.11, respectively. All
other mean differences in MCS scores were not [-3.0,
thereby not exceeding the clinical importance difference
score of three to five points.
Associations QoL by number of comorbid chronic
conditions
Chronic conditions were highly prevalent in patients with
diabetes, with 1.315 (78.5 %) diabetes patients being
identified as having one or more comorbidity, and 387
(23.1 %) having four or more comorbidities (Table 3). As
the number of comorbidities increased, both PCS and MCS
unadjusted and adjusted scores significantly decreased,
indicating lower physical and mental QoL. These effects
were most pronounced for the PCS; unadjusted and adjusted
PCS scores dropped 15.5 (95 % CI -16.8 to -14.0) and
13.3 (95 % CI -14.5 to -11.7) points, respectively, within
patients with four or more comorbid conditions compared to
patients without comorbid conditions. Additional Pearson’s
correlations confirmed the negative association between the
number of comorbidities increased, both PCS (r = -0.51)
and MCS scores decreased (r = -0.17, both P\ 0.0001),
indicating lower physical and mental QoL.
Multivariable association QoL by comorbid chronic
conditions
Since the impact of comorbidities was most profound on the
physical QoL of type 2 diabetes patients, we determined the
Table 1 Study sample characteristics and quality of life scores in type 2 diabetes patients with and without comorbidities
Diabetes patients with
comorbidities (n = 1315)
Diabetes patients without
comorbidities (n = 361)
P value
Age (years) 67.8 ± 11.1 65.4 ± 10.9 \0.001
Male [n (%)] 615 (46.8) 230 (63.8) 0.028
Low education [n (%)] 635 (48.3) 128 (35.5) \0.001
HbA1c (mmol/mol) 50.3 ± 10.3 50.5 ± 9.8 0.625
LDL (mmol/l) 2.4 ± 0.8 2.4 ± 0.8 0.678
Body mass index (kg/m2) 30.2 ± 5.5 28.6 ± 5.0 \0.001
Current smoking [n (%)] 188 (13.6) 304 (84.3) \0.001
Physical activity (range 0–7) 3.5 ± 2.5 4.3 ± 2.6 \0.001
Western ethnicity [n (%)] 1266 (96.3) 333 (92.2) \0.001
Systolic blood pressure (mm/hg) 138 ± 16.7 132.6 ± 9.8 \0.001
Diabetes duration (years) 7.4 ± 5.9 6.7 ± 5.1 0.166
Oral diabetes medication [n (%)] 959 (72.9) 268 (74.2) \0.001
Insulin use [n (%)] 334 (25.4) 68 (18.8) 0.040
Quality of life (SF-12)
PCS 42.6 ± 11.1 51.2 ± 7.9 \0.001
MCS 52.6 ± 9.2 54.5 ± 7.5 \0.001
Data are means (± SD) for continuous variables
LDL low-density lipoprotein cholesterol, SF-12 the 12-item short form health survey, PCS physical component summary, MCS mental com-
ponent summary
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association between comorbidities and PCS scores for each
chronic condition independently and in combination
(Table 4). The backwards stepwise multiple regression
procedure showed that, retinopathy, heart diseases,
atherosclerosis in abdomen/legs, lung diseases, inconti-
nence, back, neck and shoulder disorder, osteoarthritis and
chronic rheumatoid arthritis were negatively associated
with PCS scores, with Beta’s ranging between -2.96 and
-4.76 (all P\ 0.0001). This model explained 29 % of the
variance; adding demographics (age, sex, education) to the
model resulted in explaining 31 % of the variance.
We also applied the backwards regression procedure for
the association between comorbidities and MCS scores,
showing that only migraine/severe headache, intestine
disorders and incontinence were negatively associated with
MCS scores, with Beta’s of -4.07, -5.42 and -1.95
respectively (all P\ 0.001), explaining 7 % of the vari-
ance (data not shown).
Discussion
Our study showed that comorbidity is highly prevalent in
type 2 diabetes patients and has a significant impact on
both physical and mental quality of life, compared to those
without. About one-fifth of the diabetes patients reported
no comorbid disorder, and as many as 23 % had four or
more comorbidities which is supported by other studies
Table 2 Mean difference in
mental (MCS) and physical
(PCS) scores (PCS) by
comorbid chronic condition in
type 2 diabetes patients
Chronic condition N Mean difference* Mean difference*
PCS P value MCS P value
Retinopathy 162 -6.13 \0.001 -0.44 0.558
Cerebral diseases 56 -7.56 \0.001 -2.76 0.024
Myocardial infarction 41 -5.19 0.003 0.28 0.845
Heart diseases 124 -6.94 \0.001 -0.07 0.938
Cancer/malignancies 67 -1.24 0.370 -0.04 0.972
Migraine/severe headache 164 -5.36 \0.001 -6.34 \0.001
High blood pressure 645 -1.87 \0.001 -1.35 0.003
Atherosclerosis abdomen/legs 158 -8.00 \0.001 -1.67 0.028
Lung diseases 213 -7.13 \0.001 -1.81 0.006
Intestine disorders 132 -5.18 \0.001 -5.11 \0.001
Incontinence 309 -7.27 \0.001 -2.83 \0.001
Back disorder 301 -9.03 \0.001 -2.48 \0.001
Osteoarthritis 597 -8.56 \0.001 -1.59 \0.001
Chronic rheumatoid arthritis 232 -8.89 \0.001 -2.81 \0.001
Neck, shoulder disorder 324 -8.02 \0.001 -2.12 \0.001
Elbow, wrist, or hand disorder 266 -7.59 \0.001 -2.12 \0.001
* Mean difference reflects the mean MCS and PCS scores of type 2 diabetes patients with chronic con-
ditions minus the mean MCS and PCS scores of type 2 diabetes patients without chronic conditions
N number, PCS physical component summary, MCS mental component summary
Table 3 Unadjusted and adjusted Beta coefficients (95 % confidence interval) for mental (MCS) and physical (PCS) scores by number of
comorbid chronic conditions among type 2 diabetes patients (n = 1676)
Number of comorbid chronic conditions
1
n = 376
B (95 % CI)*
2
n = 317
B (95 % CI)*
3
n = 235
B (95 % CI)*
4 or more
n = 387
B (95 % CI)*
P value
MCS unadjusted -0.54 (-1.66 to 0.57) -0.71 (-1.91 to 0.49) -1.94 (-3.28 to -0.60) -4.29 (-5.65 to -2.92) \0.001
MCS adjusted** -0.58 (-1.71 to 0.54) -0.60 (-1.83 to 0.63) -1.70 (-3.11 to -0.29) -3.87 (-5.36 to -2.38) \0.0001
PCS unadjusted -2.68 (-3.91 to -1.45) -5.95 (-7.34 to -4.56) -10.27 (-11.72 to -8.82) -15.39 (-16.76 to -14.03) \0.001
PCS adjusted** -2.36 (-3.56 to -1.17) -4.98 (-6.35 to -3.61) -8.91 (-10.37 to -7.46) -13.06 (-14.47 to -11.65) \0.0001
* Reference group is number of patients (n=361) without any comorbid chronic condition
** Adjusted for age, sex, duration of diabetes, HbA1c, low-density lipoprotein cholesterol, systolic blood pressure, body mass index, insulin use,
current smoking and physical activity
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[21, 22]. Reduced physical QoL is mainly determined by
musculoskeletal and cardiovascular disorders. We found
that quality of life deteriorates significantly with increasing
numbers of comorbid conditions.
Previous studies reported that stroke and ischemic heart
disease, retinopathy, neuropathy and kidney disease have
unfavorable effects on the QoL of diabetes patients [3, 23–
25]. However, these studies were predominantly limited to
one specific concordant disease [diseases that overlap with
diabetes in their pathogenesis and management plans (e.g.,
cardiovascular diseases)]. We observed that type 2 diabetes
patients with chronic conditions experienced reduced
quality of life not only from cardiovascular disorders but
also from musculoskeletal disorders. The magnitude of the
reported QoL reductions varies between 3 and 5 points, and
even larger mean differences were found for each comor-
bid condition separately, pointing at the clinical importance
of the outcomes. The association between musculoskeletal
disorders and diabetes has been described previously [26].
We also observed a substantial dose–response relation-
ship between comorbidity and QoL, with physical QoL
decreasing steeply with an increasing number of comor-
bidities. The magnitude of the dose–response relationship
is striking: adjusted PCS scores dropped 13.3 points in
patients with four or more comorbid conditions compared
with patients without any comorbid condition, and this is
1.8 times the standard deviation. Very few studies have
reported about the dose–response relationship between
comorbidity and QoL in type 2 diabetes patients [27, 28].
Only Solli et al. found this relationship between diabetes
complications and QoL, but one-third of the sample con-
sisted of type 1 diabetes patients. The studies of both Solli
et al. and Ose et al. differed regarding setting, methods,
sample size and instruments used.
Recognizing the high prevalence of comorbidities and
its strong association with poorer QoL is important for
prioritization of care in adults with diabetes and comor-
bidity [8]. It has been suggested that patients with multiple
chronic conditions are prone to receive incomplete, inef-
ficient and ineffective care [6, 29]. Yet, the literature
regarding the relationship between comorbidity and quality
of life in diabetes is inconclusive. We previously published
that there were no differences between diabetes patient
with and without comorbidity in terms of provided care,
achievement of clinical outcomes and perceived coordi-
nation and integration of care [30] though other studies
suggested that the quality of care does differ between
diabetes patients with and without comorbidities [22, 31].
This study, consisting of a large cohort of male and
female type 2 diabetes primary care patients, gave a unique
opportunity to investigate simultaneously the prevalence,
impact and dose–response relationship between comorbid
chronic conditions and QoL. We used a valid and reliable
instrument for the primary outcome (QoL), including norm
Table 4 Physical (PCS) scores and the relationship with multiple comorbid chronic conditions among type 2 diabetes patients
Chronic condition Each comorbidity independentlya Multiple analysisb
B (95 % CIs) P value B (95 % CIs) P value
Retinopathy -3.65 (-5.19 to -2.11) \0.001 -3.88 (-5.41 to -2.35) \0.001
Cerebral diseases -2.88 (-5.49 to -0.29) 0.029 –
Myocardial infarction -0.26 (-3.30 to 2.78) 0.867 –
Heart diseases -3.96 (-5.74 to -2.19) \0.001 -4.25 (-5.97 to -2.52) \0.001
Cancer/malignancies 0.43 (-1.89 to 2.74) 0.719 –
Migraine/severe headache -0.93 (-2.48 to 0.62) 0.238 –
High blood pressure -0.19 (-1.12 to 0.74) 0.695 –
Atherosclerosis abdomen/legs -4.42 (-5.99 to -2.84) \0.001 -4.51 (-6.07 to -2.94) \0.001
Lung diseases -3.57 (-4.95 to -2.19) \0.001 -3.66 (-5.03 to -2.28) \0.001
Intestine disorders -0.54 (-2.25 to 1.16) 0.536 –
Incontinence -3.08 (-4.29 to -1.87) \0.001 -3.32 (-4.52 to -2.12) \0.001
Back disorder -4.55 (-5.82 to -3.29) \0.001 -4.76 (-6.01 to -3.51) \0.001
Osteoarthritis -4.71 (-5.75 to -3.66) \0.001 -4.74 (-5.78 to -3.70) \0.001
Chronic rheumatoid arthritis -2.74 (-4.20 to -1.28) \0.001 -2.96 (-4.38 to -1.54) \0.001
Neck, shoulder disorder -2.77 (-4.06 to -1.49) \0.001 -3.03 (-4.26 to -1.78) \0.001
Elbow, wrist, hand disorder -0.49 (-1.91 to 0.92) 0.495 –
a Linear regression analysis was used to calculate unstandardized coefficients B and 95 % confidence interval (CIs) for each comorbid chronic
condition independently
b A prediction model was calculated using a backwards stepwise regression procedure starting with all comorbid chronic conditions and then
eliminating all variables which did not contribute (P[ 0.1) to the model
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scores, and had detailed information on multiple comor-
bidities from both survey and administrative data. Yet,
some study limitations need to be addressed. First, an
important consideration in interpreting our results is that
the current study employed cross-sectional data, so causal
relationships between type 2 diabetes, comorbidity, and
QoL cannot be established. Second, this study may not
have fully captured the comorbid conditions that determine
QoL. We used an existing and regularly used list that
included sixteen chronic somatic conditions that are
prevalent in at least 1 % of the Dutch population. Besides
somatic comorbidity, there is a proportion of type 2 dia-
betes patients that suffer from psychiatric comorbidity. It is
known that depression and type 2 diabetes often co-occur
[32] and that depression negatively affects quality of life
[33]. It is likely that including depression in the list of
chronic conditions would have had detrimental effects on
the mental QoL scores in our sample. On the other hand,
assuming that depression is present in our diabetes sample
one would expect to see MCS scores, in both diabetes
patients with and without chronic conditions, that were
more deviant from the norm MCS of people aged 60–69.
However, we cannot exclude the fact that a proportion of
patients could have been detected as positive for depression
by using an appropriate screening tool. Third, we used self-
reports to determine the chronic condition status. Self-re-
port may be less reliable than medical records. The meth-
ods used to identify comorbid conditions could influences
the prevalence figures [34]. The main reason for not using
the medical records is that these co-morbidities were not
well registered and registered ambiguously in the selected
eight different care groups. For this reason these data were
not requested. Therefore, we decided to use the self-report
questionnaire. However, some studies suggested that self-
report data predict QoL as well or even better than comor-
bidity data from medical records [35–37]. Fourth, there was
no information available on the reasons for non-response.
We were unable to perform a non-responder analysis since
we do not have an informed consent of the non-responders
to perform a linkage between their survey-id and the avail-
able registration data based on the larger observational study
from which our study sample was derived. All respondents
gave informed consent for linking the survey data to their
medical records for the purpose of the study. Therefore, we
were (only) able to assess whether the respondents in our
survey sample were representative of the total study popu-
lation. We compared both groups in terms of sex, diabetes
duration and age, and no major differences emerged.
Therefore, we expect no substantial bias for the primary
outcomes and subsequent generalizability of the results. Yet,
one cannot fully rule out the possibility that the non-re-
sponders could have had some impact on the results.
Finally, the present study was predominantly limited to
a sample of patients with Western ethnicity, which may
limit the generalizability. As yet, it is not clear whether the
relationship between type 2 diabetes, comorbidity, and
QoL is consistent across different ethnic populations.
Interestingly, in adults with diabetes, ethnic minorities had
better physical QoL than whites [38].
In conclusion, comorbidities among type 2 diabetes
patients are highly prevalent, have a profound impact on
the patient’s QoL, which deteriorates substantially with
increasing numbers of comorbid conditions. Reduced
physical QoL is mainly determined by musculoskeletal and
cardiovascular disorders. The results stress de cumulative
impact of comorbidity on the patient’s quality of life. It
also shows that the illness burden experienced by diabetes
patients is not only associated with diabetes itself and its
concordant diseases, but in particular suffer from comor-
bidities that are unrelated with the pathogenesis and man-
agement plans of type 2 diabetes. Improved management of
diabetes, including its allied comorbid chronic disorders,
may ultimately lead to a better quality of life for the dia-
betes patient.
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